Ajinomoto Althea Builds San Diego Pharmaceutical Manufacturing Facility
Ajinomoto Althea is building a 57,000-sf pharmaceutical manufacturing facility in San Diego. Accommodating all stages of development from preclinical production through commercial supply, the project will support the manufacture of highly potent drug products as well as Antibody Drug Conjugates (ADCs). The facility will enable the safe handling and manipulation of compounds with very low occupational exposure limits (OEL) while maintaining aseptic conditions and cGMP compliance.